中国抗癌协会原发性肝癌患者指南

2021-02-08 中国抗癌协会 中国抗癌协会官网

长期以来,大家都是“谈癌色变”,当医生告知您的肝脏长了肿瘤以后,想必您一定感到悲伤和恐惧,您的身心痛苦我们非常

中文标题:

中国抗癌协会原发性肝癌患者指南

发布机构:

中国抗癌协会

发布日期:

2021-02-08

简要介绍:

长期以来,大家都是“谈癌色变”,当医生告知您的肝脏长了肿瘤以后,想必您一定感到悲伤和恐惧,您的身心痛苦我们非常理解,但同时,我们更希望您能够全面地认识肝癌,并科学地与肝癌做斗争。事实上,这些年来随着生命科学的进步,新的治疗手段和治疗药物不断出现,一直在刷新肝癌患者的生存时间,尤其是免疫药物治疗更是给肝癌的治疗带来了新的曙光,开创了肝癌治疗的新纪元。然而目前很多肝癌患者对于肝癌是如何发生的以及得了肝癌之后要如何治疗仍然知之甚少。有鉴于此,我们中国抗癌协会集合了全国顶级的肝癌治疗专家撰写了这份肝癌患者诊疗指南,这也是由多学科的权威专家集体编写的中国第一本肝癌患者指南,它全面、科学地介绍了肝癌的疾病基础和诊疗知识,希望它能够成为您抗癌路上的帮手,让您知道您并不孤单,还有很多医疗专业人士在和您一起与肝癌做斗争。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国抗癌协会原发性肝癌患者指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9689b1c0020e1248, title=中国抗癌协会原发性肝癌患者指南, enTitle=, guiderFrom=中国抗癌协会官网, authorId=0, author=, summary=长期以来,大家都是“谈癌色变”,当医生告知您的肝脏长了肿瘤以后,想必您一定感到悲伤和恐惧,您的身心痛苦我们非常, cover=https://img.medsci.cn/2021315/1615737957399_2020535.jpg, journalId=0, articlesId=null, associationId=18, associationName=中国抗癌协会, associationIntro=中国抗癌协会是中国科学技术协会主管、中华人民共和国民政部注册登记、具有独立法人资格的肿瘤学科唯一的国家一级学会。成立以来积极开展肿瘤学科的临床与基础性研究,创建肿瘤专业继续教育基地,创办多种形式的肿瘤学习培训班,积极推广新成果、新技术,举办国内外肿瘤学术会议,为国内外肿瘤研究者提供了广阔的学术交流平台,促进了我国肿瘤防治水平的提高。, copyright=0, guiderPublishedTime=Mon Feb 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>长期以来,大家都是&ldquo;谈癌色变&rdquo;,当医生告知您的肝脏长了肿瘤以后,想必您一定感到悲伤和恐惧,您的身心痛苦我们非常理解,但同时,我们更希望您能够全面地认识肝癌,并科学地与肝癌做斗争。事实上,这些年来随着生命科学的进步,新的治疗手段和治疗药物不断出现,一直在刷新肝癌患者的生存时间,尤其是免疫药物治疗更是给肝癌的治疗带来了新的曙光,开创了肝癌治疗的新纪元。然而目前很多肝癌患者对于肝癌是如何发生的以及得了肝癌之后要如何治疗仍然知之甚少。有鉴于此,我们中国抗癌协会集合了全国顶级的肝癌治疗专家撰写了这份肝癌患者诊疗指南,这也是由多学科的权威专家集体编写的中国第一本肝癌患者指南,它全面、科学地介绍了肝癌的疾病基础和诊疗知识,希望它能够成为您抗癌路上的帮手,让您知道您并不孤单,还有很多医疗专业人士在和您一起与肝癌做斗争。</p>, tagList=[TagDto(tagId=1097, tagName=原发性肝癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1097, guiderKeyword=原发性肝癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=1, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9434, appHits=695, showAppHits=0, pcHits=1469, showPcHits=8736, likes=3, shares=39, comments=17, approvalStatus=1, publishedTime=Mon Mar 15 00:06:14 CST 2021, publishedTimeString=2021-02-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 15 00:06:04 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 10:28:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国抗癌协会原发性肝癌患者指南.pdf)])
中国抗癌协会原发性肝癌患者指南.pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1065716, encodeId=ddb91065e164e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5da5557703, createdName=苏苏姜, createdTime=Mon Nov 01 09:21:20 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056097, encodeId=a124105609e1a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d015596193, createdName=ms2000001066958081, createdTime=Wed Sep 29 13:34:42 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052989, encodeId=bbd11052989f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sun Sep 19 11:16:33 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052837, encodeId=1080105283e9c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sat Sep 18 17:05:04 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010644, encodeId=b6111010644ca, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/92f6e182ea8b421582d5c790cc288258/8357c9fed50a446796cc4ab0dabf8ff8.jpg, createdBy=ddfc5575218, createdName=高利飞, createdTime=Mon Aug 23 15:59:38 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-11-01 苏苏姜

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1065716, encodeId=ddb91065e164e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5da5557703, createdName=苏苏姜, createdTime=Mon Nov 01 09:21:20 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056097, encodeId=a124105609e1a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d015596193, createdName=ms2000001066958081, createdTime=Wed Sep 29 13:34:42 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052989, encodeId=bbd11052989f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sun Sep 19 11:16:33 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052837, encodeId=1080105283e9c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sat Sep 18 17:05:04 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010644, encodeId=b6111010644ca, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/92f6e182ea8b421582d5c790cc288258/8357c9fed50a446796cc4ab0dabf8ff8.jpg, createdBy=ddfc5575218, createdName=高利飞, createdTime=Mon Aug 23 15:59:38 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-09-29 ms2000001066958081

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1065716, encodeId=ddb91065e164e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5da5557703, createdName=苏苏姜, createdTime=Mon Nov 01 09:21:20 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056097, encodeId=a124105609e1a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d015596193, createdName=ms2000001066958081, createdTime=Wed Sep 29 13:34:42 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052989, encodeId=bbd11052989f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sun Sep 19 11:16:33 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052837, encodeId=1080105283e9c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sat Sep 18 17:05:04 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010644, encodeId=b6111010644ca, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/92f6e182ea8b421582d5c790cc288258/8357c9fed50a446796cc4ab0dabf8ff8.jpg, createdBy=ddfc5575218, createdName=高利飞, createdTime=Mon Aug 23 15:59:38 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-09-19 ms1000002121020113

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1065716, encodeId=ddb91065e164e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5da5557703, createdName=苏苏姜, createdTime=Mon Nov 01 09:21:20 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056097, encodeId=a124105609e1a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d015596193, createdName=ms2000001066958081, createdTime=Wed Sep 29 13:34:42 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052989, encodeId=bbd11052989f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sun Sep 19 11:16:33 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052837, encodeId=1080105283e9c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sat Sep 18 17:05:04 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010644, encodeId=b6111010644ca, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/92f6e182ea8b421582d5c790cc288258/8357c9fed50a446796cc4ab0dabf8ff8.jpg, createdBy=ddfc5575218, createdName=高利飞, createdTime=Mon Aug 23 15:59:38 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-09-18 ms1000002121020113

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1065716, encodeId=ddb91065e164e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5da5557703, createdName=苏苏姜, createdTime=Mon Nov 01 09:21:20 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056097, encodeId=a124105609e1a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d015596193, createdName=ms2000001066958081, createdTime=Wed Sep 29 13:34:42 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052989, encodeId=bbd11052989f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sun Sep 19 11:16:33 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052837, encodeId=1080105283e9c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887b5610574, createdName=ms1000002121020113, createdTime=Sat Sep 18 17:05:04 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010644, encodeId=b6111010644ca, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210817/92f6e182ea8b421582d5c790cc288258/8357c9fed50a446796cc4ab0dabf8ff8.jpg, createdBy=ddfc5575218, createdName=高利飞, createdTime=Mon Aug 23 15:59:38 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-08-23 高利飞

    0